AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05127460 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AI-enabled ECG-based Screening Tool
Description: Primary care clinicians in the intervention group had access to the report, which displayed whether the AI-ECG result was positive or negative. The system will send a message to corresponding physicians if positive finding.
Study NCT05807282 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interventions to Decrease Heat Stress among Latinx Farmworkers in Idaho
Description: The interventions will be developed in collaboration with our study partners and will include increasing access to shade at the workplace, providing hydration packs to participants, and providing education regarding the signs and symptoms of occupational heat stress.
Study NCT06522425 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mindfulness-based serious games
Description: The intervention consists of a single session using a digital serious game designed to teach mindfulness techniques for pain management. In addition to explaining mindfulness concepts, the game provides a variety of mindfulness exercises to help users manage and reduce pain perception. For example, it involves relaxation through breathing or becoming aware of the state of one's body and mind. Additionally, it includes various interaction elements such as touch, voice, and motion controls to increase user immersion.
Study NCT05664893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ribociclib Oral Tablet
Description: 600mg per day during registration phase (3 cycles); de-escalation phase (600 to 200mg per day associated to radiotherapy) during 3 other cycles; maintenance phase until 24 months of treatment in total (600mg per day).~All over th etimme, hormonotherapy is received in concomitance
Study NCT05043766 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF614
Description: PF614 is an oxycodone prodrug
Study NCT05279872 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zanubrutinib
Description: Zanubrutinib 80mg po qd 6 weeks
Study NCT05251597 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: green exercise with aerobic exercise
Description: Green exercise is a type of exercise done outdoors. It is an advantageous type of exercise in benefiting from sunlight and reducing anxiety. It is mostly applied in the form of brisk walking in the open air.
Study NCT05043766 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PF614
Description: PF614 is an oxycodone prodrug
Study NCT05043766 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naltrexone Hydrochloride
Description: Naltrexone HCl tablets, 50 mg, will be used to block the opioid effects in healthy volunteers
Study NCT05043766 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Naltrexone Hydrochloride
Description: Naltrexone HCl tablets, 50 mg, will be used to block the opioid effects in healthy volunteers
Study NCT05043766 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: OxyContin
Description: Bioequivalence single-dose comparison to OxyContin
Study NCT05598970 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital application supported CHW Parenting Intervention
Description: All pregnant women served by the trained CHW will be invited to participate in the Parenting program, from when the mother is at least 20 weeks pregnant and less than 32 weeks pregnant with the target child for a period of 15 months. CHWs will visit pregnant women at least 3 times during their pregnancy and at least 16 times following delivery. In addition to the individual home visits, the CHWs will organise bi-weekly in-community group sessions for children aged 6-12 months and their primary caregivers, focusing on caregiver-child interaction and stimulation activities.~The immediate supervisors Health Care Workers (HCWs) of the CHWs will be trained to closely monitor CHWs activities and progress made. HCWs and CHWs will in turn be supervised and supported by district level Council Health Management Team (CHMT).~Parenting services will be provided to all target children of these eligible caregivers, irrespective of their learning or physical abilities.
Study NCT05598970 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Unconditional Cash Transfer only Intervention fixed amount
Description: The fixed cost for delivering the Parenting only Intervention was calculated to be 32,000 TZS. This cost is added to the average of maximum and minimum amount transferred on a bi-monthly basis to similar pregnant women under TASAF: 77,000 TZS. Therefore, in the 'Unconditional Cash Transfer fixed amount' treatment arm, the transfer will be 109,000 TZS (32,000 TZS + 77,000 TZS).
Study NCT05598970 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Unconditional Cash Transfer Intervention
Description: Families will receive from 5-7 months pregnancy over a period of 15 months a bi-monthly unconditional cash transfer, which equals the average of maximum and minimum amount transferred on a bi-monthly basis to similar pregnant women under Tanzania Social Action Fund (TASAF), i.e., Tanzania's National Cash Transfer program.
Study NCT05598970 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Unconditional Cash Transfer only Intervention vary amount
Description: The rationale for the levels of the varying UCT amounts is to keep them comparable with i) the bi-monthly cost of the parenting program per family, ii) the bi-monthly cash transfers disbursed under TASAF, and iii) the sum of the bi-monthly cost of the parenting program and the bi-monthly cash transfer disbursed under TASAF. The fixed cost for delivering the Parenting Intervention was calculated to be 32,000 TZS. This cost is added to the average of maximum and minimum amount transferred on a bi-monthly basis to similar pregnant women under TASAF: 77,000 TZS. Therefore, in the 'Unconditional Cash Transfer only vary amount' group, each of the amounts vary individually (32,000 TZS; 77,000 TZS; 109,000 TZS).
Study NCT05989581 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Labetalol or Nifedipine
Description: The choice of anti-HTN will be based on the patient and provider's experience and preference. First line anti-HTN recommended in pregnancy- labetalol or nifedipine- will be administered to patients. At least weekly, a study team member will review the participants' BPs and, if randomized to intervention and a higher dose is needed to maintain BPs \<130/80 mmHg, the study team member will communicate with the clinical team, led by a University of Alabama Maternal Fetal Medicine Attending, in order to ensure coordination between the research and clinical care teams. Labetalol will be initiated at 200 mg twice daily and escalated in 200mg /dose daily until BP\<130/80mmHg to a maximum dose of 2400mg/day. Procardia will be initiated at 30mg XL once daily and uptitrated in 30mg increments until a maximum dose of 120mg daily. Postpartum, titration will occur in similar fashion. The patient will be transitioned to her primary care provider for BP management after the 6-week postpartum visit.
Study NCT06283017 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hypoglossal nerve stimulation
Description: Device stimulation of the hypoglossal nerve
Study NCT04804137 — intervention group
Intervention type: OTHER
Intervention: Blood
Description: Blood samples are taken at each visit to the day hospital for a programmed injection of immunotherapy.
Study NCT04804137 — intervention group
Intervention type: OTHER
Intervention: sputum
Description: induced by saline aerosol sputum during each visit to the day hospital for a programmed injection of immunotherapy.
Study NCT04804137 — intervention group
Intervention type: OTHER
Intervention: saliva
Description: spontaneous saliva during each visit to the day hospital for a programmed injection of immunotherapy.
Study NCT04804137 — intervention group
Intervention type: OTHER
Intervention: stool
Description: Stool analyses will be carried out on a sample taken by the patient at home and brought back at the time of a day hospital.
Study NCT05238662 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: pedicle screw fixation on one side and intervertebral cage on the other sided
Description: pedicle screw fixation on one side and intervertebral cage on the other sided
Study NCT05238662 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: pedicle screw fixation and interbody cage on the same side
Description: pedicle screw fixation and interbody cage on the same side
Study NCT06057064 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biological: AZD3152
Description: 300 mg single dose of AZD3152 IM
Study NCT06057064 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Biological: Placebo
Description: Single dose of Placebo IM (0.9% sodium chloride)
Study NCT01240382 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3% DE-089 ophthalmic solution
Study NCT01240382 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.1% sodium hyaluronate ophthalmic solution
Study NCT04617821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab paclitaxel plus gemcitabine
Description: Albumin-bound paclitaxel and gemcitabine are given intravenous infusion, repeated every 4 weeks for 1, 8, and 15 days, for a total of 4 to 6 cycle.
Study NCT04617821 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: mFOLFIRINOX
Description: Intravenous oxaliplatin for 2 hours, day 1;Intravenous infusion of calcium formyl tetrahydrofolate (LV) for 2 h, day 1;Irinotecan intravenous infusion is added 30 minutes later for 90 minutes, day 1;Intravenous infusion of 5-fluorouracil (5-FU) continued for 46 hours.Repeat every 2 weeks for a total of 4-6 cycles.
Study NCT06275269 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound-Guided
Description: Ultrasound-Guided Triamcinolone Injection
Study NCT06275269 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Translaryngeal Endoscopic Mucosal Injection
Description: Translaryngeal Endoscopic Mucosal Injection of Triamcinolone
Study NCT06228404 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enhanced autologous PSMA-CAR T
Description: 3 escalated dosing cohorts are designed to explore safety and efficacy of enhanced autologous PSMA-CAR T:~cohort A： CART-PSMA cells 0.25×106/kgBW, following lymphodepleting chemotherapy with cyclophosphamide 300 mg/m2/day and fludarabine 30 mg/m2/day given according to protocol;~cohort B： CART-PSMA cells 0.75×106/kgBW，following lymphodepleting chemotherapy with cyclophosphamide 300 mg/m2/day and fludarabine 30 mg/m2/day given according to protocol;~cohort C： CART-PSMA cells 2×106/kgBW，following lymphodepleting chemotherapy with cyclophosphamide 300 mg/m2/day and fludarabine 30 mg/m2/day given according to protocol;
Study NCT05138146 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 609A
Description: 609A 200mg,IV, Day 1of each treatment cycle, up to disease progression or intolerable toxicity, death, early withdrawal from the study or loss to follow-up, withdrawal of consent, or the end of the treatment period, whichever occurs first.~Every 3 weeks a treatment cycle.
Study NCT05138146 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: doxorubicin hydrochloride
Description: 60mg/m2 or 75mg/m2, IV, Day1of the1-6th treatment cycles only. Every 3 weeks a treatment cycle.
Study NCT06393231 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: acupuncture
Description: Acupuncture is applied to ST8, GB14, BL12, SJ23, ST2, SI18, ST4, ST7, RN24, Ex-HN16, SJ17 and LI4 on the affected side and needles are retained for half an hour.Add infrared irradiation therapy in the same time
Study NCT06393231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: acupuncture
Description: Acupuncture is applied to ST8, GB14, BL12, SJ23, ST2, SI18, ST4, ST7, RN24, Ex-HN16, SJ17 and LI4 on the affected side and needles are retained for half an hour.Add infrared irradiation therapy in the same time
Study NCT06405893 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Mindful breathing exercise
Description: Participants do a 10 minute guided mindful breathing exercise or participants do listen to a 10 minute control recording
Study NCT06405893 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindful breathing exercise
Description: Participants do a 10 minute guided mindful breathing exercise or participants do listen to a 10 minute control recording
Study NCT06523127 — intervention group
Intervention type: OTHER
Intervention: Recording data from the ICU stay and the post-ICU follow-up.
Description: Record analysis of the post-ICU follow-up with the Interpretative Phenomenological Analysis
Study NCT05394168 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HLX53
Description: There are 5 preset dose groups, namely 30mg/QW, 150mg/QW, 400mg/QW, 1000mg/Q3W and 2000mg/Q3W, administered by intravenous infusion.
Study NCT05489575 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active CPAP
Description: Continuous positive airway pressure (CPAP) is applied at 8, 10, or 12 cm H20. The active CPAP level will be determined during a CPAP titration trial
Study NCT05489575 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham CPAP
Description: Sham continuous positive airway pressure applied at \<4 cm H2O
Study NCT05489575 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sleeping in a head-up tilt (HUT) position
Description: Sleeping with the whole bed tilted head-up by 10 degrees or with the head elevated by 13-14 inches.
Study NCT05246449 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: individualised treatment plan (VitalCare) and associated remote medical monitoring
Description: VitalCare is a treatment plan to help in the personalisation of patient care.
Study NCT04960267 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Use of pre-peritoneal drainage after rTAPP
Description: Use of pre-peritoneal drainage after rTAPP
Study NCT05518721 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Hallux Rigidus Treatment
Description: Participants will receive either a synthetic cartilage implant or dermal interposition arthroplasty
Study NCT05508958 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Anterior approach
Description: Anterior approach
Study NCT05508958 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Posterolateral approach
Description: Posterolateral approach
Study NCT06473441 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tele-Rehabilitation Therapy
Description: Twice-weekly sessions with remote supervision and guidance from therapists.
Study NCT06473441 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Education
Description: Health education based on individual assessments.
Study NCT06473441 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise Prescription
Description: Exercise prescription tailored to individual needs.
Study NCT06473441 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home Exercise Equipment Use
Description: Use of a home exercise bike, resistance bands, respiratory muscle training device, and a portable heart rate monitor.
Study NCT06473441 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise Log
Description: Logging daily exercise intensity and duration in a rehabilitation diary
Study NCT06473441 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Follow-Up Calls
Description: Regular follow-up calls to monitor progress and address any issues.
Study NCT06550492 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: smoke filtering electrocautery device
Description: A smoke-filtering electrocautery device was used during surgery.
Study NCT06550492 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: double mask
Description: A double-layer mask was used during the operation.
Study NCT05103787 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: deep parasternal intercostal plane block
Description: Twenty milliliters of 0.25% bupivacaine will be placed bilaterally in the fascial plane between internal intercostal muscle and transversus thoracis muscle at intercostal space 4 or 5, lateral from sternum, with ultrasound guidance using high-frequency linear transducer.
Study NCT05103787 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: deep parasternal intercostal plane block
Description: Twenty milliliters of 0.25% bupivacaine will be placed bilaterally in the fascial plane between internal intercostal muscle and transversus thoracis muscle at intercostal space 4 or 5, lateral from sternum, with ultrasound guidance using high-frequency linear transducer.
Study NCT05318651 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Kwit SAS - smoking cessation app
Description: Kwit is a mobile app for smoking cessation. Different CBT techniques are used by the app already been proved as effective : Case analysis craving tool, Achievements badges,Diary, Goal (outcome) setting, A 9-steps preparation program, psychological education, Emotional monitoring, Access to groups on social networks, different strategies ( NRT/water/meditation), Motivational cards.
Study NCT05704556 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VX-548
Description: Tablets for oral administration.
Study NCT05153265 — intervention group
Intervention type: OTHER
Intervention: Survey
Description: There will be no interventions for study participants. Participants will be asked to complete a survey.
Study NCT05485311 — intervention group
Intervention type: OTHER
Intervention: visual analog scale
Description: Data collection was carried out at all stages of treatment: medical and nursing brigade, military mobile hospital, military medical clinical center, during rehabilitation, within 12 months of the injury.
Study NCT05103787 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: control
Description: Skin puncture with needle will be performed on the same location as the treatment group without administration of local anesthetics.
Study NCT05103787 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: control
Description: Skin puncture with needle will be performed on the same location as the treatment group without administration of local anesthetics.
Study NCT05406323 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Web-Based Fall Prevention Program
Description: Health education: This intervention consisted of seven health issues which are Fall among elderly, fall risk factors,  fall prevention interventions-exercise,  fall prevention interventions-healthy diet,  fall prevention interventions- drug use, fall prevention interventions- vision, fear of falling.~Exercise: This intervention is the exercise that is a combination of balance and strengthening exercises (8 exercise). Participants will do the exercises at least three days a week (along 6 week).~Safe home environment: This intervention is aimed at providing a fall-safe home environment for the participants. In this context, the participants will watch the video on creating a safe home environment for falling. Participants will also be asked to answer the Home Safety Check Form for Falls to make their home more fall-proof. In this form, according to the answers given by the participants, suggestions will be given to prevent the risks of falling in the home environment.
Study NCT05774314 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community Health Worker Intervention
Description: Communities that are randomized into the Treatment arm will receive the Flourish program. Communities with a Flourish program will select and train a Community Health Worker from the Transform program participants. At the end of the Transform program, a Savings Group will be formed from the Transform program participants. The Savings Group will nominate households to participate in the Flourish program and research study. The Community Health Worker will approach the nominees and attempt to enroll them into the Flourish program and research study. If the nominees agree to be enrolled in the Flourish program, the Community Health worker will provide screening, referral, counseling, and treatment services to the household for the duration of the study.
Study NCT06516770 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation
Description: The subject will receive the tDCS using 5X7 cm electrodes. The anodal electrode will be placed on M1 representing the back muscles (1 cm anterior and 4 cm lateral to the vertex), while cathodal electrode will be placed on contralateral supraorbital area. The intensity will be set at 2 mA with 10-second fade in/out. The subject will be stimulated by tDCS for 20 minutes
Study NCT06516770 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation
Description: The participants will receive the NMES using interferential mode (6000 Hz, beat frequency 20-50 Hz, scanning effect) on bilateral LM. The intensity will be set at the subject's maximum tolerance. Stimulation will be set at 10 seconds on and 60 seconds off to minimize muscle fatigue. The total NMES time is 20 minutes.
Study NCT06516770 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor control exercise
Description: The participant will be instructed to perform co-contraction of transverse abdominis and lumbar multifidus muscle, while performing self-selected pace forward bend. Emphasis will be given to move in control manner (smooth and symmetrical movement). The participant will perform 4 minutes of continuous movement for 4 sets with 1 minute rest between sets.
Study NCT06516770 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Isometric exercise
Description: The participant will be instructed to perform isometric back extension exercise in modified Sorensen position. The participant will hold 60 seconds in neutral position for 5 repetitions with 3 minutes rest between repetitions.
Study NCT04429958 — intervention group
Intervention type: OTHER
Intervention: GDM
Description: different degrees of hyperglycaemia during pregnancy
Study NCT06296511 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: 60 min of treadmill exercise performed at 70% of peak oxygen uptake.